A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

NCT04772989 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
Non Small Cell Lung Cancer (NSCLC)
Melanoma
Cervical Cancer
Multiple Myeloma
Lymphoma, Non-Hodgkin
Diffuse Large B Cell Lymphoma (DLBCL)
Gastric Cancer
Gastroesophageal Junction Adenocarcinoma
Esophageal Cancer

Interventions

DRUG: AB308
DRUG: Zimberelimab

Sponsor

Arcus Biosciences, Inc.

Collaborators

[object Object]